Want to join the conversation?
$GT, which competes with Bridgestone Corporation and Michelin, said it continues to target $2.1-2.2Bil in segment operating income in 2016. In cost savings versus inflation, the company expects a benefit of $135MM for the full year 2016. About $35MM in incremental cost in the Americas segment operating income is expected in 2Q16.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.